Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-18 · accession 0001437749-22-009262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-19 | 2022-04-18 | BLFS | DE GREEF RODERICK | COO, Pres | S - Sale | $17.59 | -18.5K | 129.8K | -12% | -$325.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | S | D | 18,530 | $17.59 | 129,780 | D | — | — | (F1) The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. |